Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 349,894 | 362,506 | 364,618 | 376,771 | 159,846 |
| Receivables | 36,811 | 30,406 | 29,760 | 29,450 | 24,029 |
| Inventories | 45,345 | 37,982 | 32,171 | 27,511 | 26,655 |
| TOTAL | $443,270 | $439,112 | $431,733 | $439,826 | $216,938 |
| Non-Current Assets | |||||
| PPE Net | 7,340 | 6,504 | 5,851 | 4,982 | 3,895 |
| Intangibles | 14,003 | 14,472 | 14,883 | 837 | 809 |
| Other Non-Current Assets | 28,204 | 25,791 | 10,838 | 8,675 | 8,637 |
| TOTAL | $49,547 | $46,767 | $31,572 | $14,494 | $13,341 |
| Total Assets | $492,817 | $485,879 | $463,305 | $454,320 | $230,279 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,749 | 5,971 | 3,034 | 3,927 | 3,324 |
| Accrued Expenses | 17,841 | 14,640 | 15,251 | 10,753 | 11,593 |
| Other current liabilities | 7,769 | 9,940 | 7,815 | 9,449 | 8,580 |
| TOTAL | $42,350 | $42,803 | $33,181 | $30,014 | $28,165 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,991 | 12,252 | 7,081 | 5,885 | 4,668 |
| Other Non-Current Liabilities | 28,422 | 28,572 | 14,949 | 13,370 | 12,463 |
| TOTAL | $39,338 | $35,634 | $24,739 | $21,111 | $18,780 |
| Total Liabilities | $81,688 | $78,437 | $57,920 | $51,125 | $46,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,627 | 134,313 | 134,077 | 133,726 | 46,425 |
| Common Shares | 135 | 134 | 126 | 125 | 24 |
| Retained earnings | -22,225 | -21,627 | -19,606 | -18,415 | -19,835 |
| Other shareholders' equity | 330 | 1,117 | 1,240 | 885 | 195,170 |
| TOTAL | $411,129 | $407,442 | $405,385 | $403,195 | $183,334 |
| Total Liabilities And Equity | $492,817 | $485,879 | $463,305 | $454,320 | $230,279 |